DURECT

$1.74
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.10 (-5.41%) Today
-$0.01 (-0.57%) As of 8:09 PM UTC after-hours

Why Robinhood?

You can buy or sell DURECT and other stocks, options, and ETFs commission-free!

About DRRX

DURECT Corp. focuses in advancing novel and potentially lifesaving investigational therapies derived from its Epigenetic Regulator Program. Its pipeline is called DUR-928, an endogenous sulfated oxysterol and an epigenetic regulator.

CEO
James E. Brown
Employees
81
Headquarters
Cupertino, California
Founded
1998
Market Cap
401.83M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.01M
High Today
$1.84
Low Today
$1.75
Open Price
$1.83
Volume
771.04K
52 Week High
$2.96
52 Week Low
$1.52

DRRX Earnings

-$0.05
-$0.01
$0.03
$0.07
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 10, After Hours

You May Also Like

BHLB
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure